A Study of the Effect of Laughter Therapy on the Mental Health and Quality of Survival of Hematopoietic Stem Cell Transplant Patients

Launched by INSTITUTE OF HEMATOLOGY & BLOOD DISEASES HOSPITAL, CHINA · Jan 21, 2025

Keywords

ClinConnect Summary

This clinical trial is studying how laughter therapy might help improve the mental health and quality of life for patients who are receiving a hematopoietic stem cell transplant, which is a treatment for certain blood cancers. The main goal is to see if laughter can make patients feel better mentally and improve their overall well-being after the transplant. Researchers will also look at how patients' mental health and quality of life change over the first year after their transplant.

To participate in this study, patients need to be at least 16 years old and have a confirmed blood cancer diagnosis. They should be getting their first stem cell transplant and be able to read and write enough to fill out some questionnaires. However, individuals with serious mental health issues or those who are critically ill cannot join. If you decide to participate, you can expect to take part in laughter therapy sessions and complete assessments about your health and feelings at different times during the study.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with a pathologically confirmed diagnosis of hematologic malignancy; Patients undergoing their first hematopoietic stem cell transplant; Age ≥ 16 years; Those who have some reading and writing ability; Those who can cooperate in completing the questionnaires and assessments; Informed consent and voluntary participation in the study.
• Exclusion Criteria:
• • Those with severe mental illness or personality disorders; Those who cannot operate a smartphone independently; Those with severe visual and hearing impairments; Those who are critically ill and cannot receive the intervention.